| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 04/01/2021 | 3. Issuer Name and Ticker or Trading Symbol BeiGene, Ltd. [ BGNE ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares(1) | 203,983 | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Share Option (Right to Buy) | (2) | 07/13/2026 | Ordinary Shares | 233,948(3) | 2.29 | D | |
| Share Option (Right to Buy) | (4) | 06/26/2027 | Ordinary Shares | 999,999(3) | 3.49 | D | |
| Share Option (Right to Buy) | (5) | 06/25/2028 | Ordinary Shares | 364,208(3) | 12.34 | D | |
| Share Option (Right to Buy) | (6) | 06/04/2029 | Ordinary Shares | 558,285(3) | 9.23 | D | |
| Share Option (Right to Buy) | (7) | 06/16/2030 | Ordinary Shares | 525,564(3) | 13.42 | D | |
| Explanation of Responses: |
| 1. Includes 176,241 shares underlying unvested restricted share units. |
| 2. Fully vested on July 31, 2020. |
| 3. The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. |
| 4. These securities vest over a four-year period as follows: 25% on June 27, 2018 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. |
| 5. These securities vest over a four-year period as follows: 25% on June 26, 2019 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. |
| 6. These securities vest over a four-year period as follows: 25% on June 5, 2020 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. |
| 7. These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. |
| Remarks: |
| Exhibit List - Exhibit 24.1 - Power of Attorney |
| /s/ Qing Nian, as Attorney-in-Fact | 04/09/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
